BMC Medical Genomics
Not applicable
Ultra-sensitive molecular detection of gene fusions from RNA using ASPYRE
12-Oct-2022
New data demonstrates novel genomic technology provides ultra-sensitive detection of gene fusions from RNA
Biofidelity CMO Dr. Wendy Levin says the company has developed a novel genomic assay that can analyze DNA and RNA concurrently for NSCLC. Credit: Biofidelity
Additional Media
Scientists at Biofidelity have published a new paper in BMC Medical Genomics that describes how its ASPYRE technology can perform ultra-sensitive molecular detection of gene fusions from RNA. Credit: Biofidelity
Keywords
Article Information
Journal
BMC Medical Genomics
Subject of Research
Not applicable
Article Publication Date
2022-10-12
Article Title
Ultra-sensitive molecular detection of gene fusions from RNA using ASPYRE
Contact Information
How to Cite This Article
APA:
Dowling & Dennis PR. (2022, October 18). New data demonstrates novel genomic technology provides ultra-sensitive detection of gene fusions from RNA. Brightsurf News. https://www.brightsurf.com/news/8OM4NME1/new-data-demonstrates-novel-genomic-technology-provides-ultra-sensitive-detection-of-gene-fusions-from-rna.html
MLA:
"New data demonstrates novel genomic technology provides ultra-sensitive detection of gene fusions from RNA." Brightsurf News, Oct. 18 2022, https://www.brightsurf.com/news/8OM4NME1/new-data-demonstrates-novel-genomic-technology-provides-ultra-sensitive-detection-of-gene-fusions-from-rna.html.